OBJECTIVES: Skeletal myoblast sheet (SMB) transplantation, a method used for treating failing hearts, results in the secretion of cytokines that improve heart function. Enhancing the survival rate of implanted myoblasts should yield more continuous and effective therapies. We hypothesized that laminin-211 (merosin), a major component of skeletal muscle extracellular matrix (ECM), which mediates cell-to-ECM adhesion by binding to a-dystroglycan (aDG) on muscle cells, could inhibit detachment of implanted myoblasts from host myocardia.
INTRODUCTION
Implantation of autologous skeletal myoblast (SMB) cell sheets for treatment of ischemic cardiomyopathy has been shown to improve left ventricular (LV) function and to reverse LV remodelling [1] [2] [3] . Its cardio-protective effects occur through autocrine or paracrine mechanisms [4] . However, transplanted cells can be gradually ejected from the recipient heart as a result of instability in the scaffold [5] [6] [7] . The detachment of implanted cells is accompanied by a concurrent decrease in the paracrine effects of the transplanted tissue. As such, developing an approach to improve the survival and functionality of implanted cells could yield enhanced therapeutic outcomes from cell implantation [8, 9] . To address this possibility, we focused on the extracellular matrix (ECM) as a scaffold for implanted cells. Skeletal muscle cells are attached to a basement membrane, which in turn is attached to an ECM. The skeletal muscle basement membrane performs various crucial functions, including maintenance of muscle integrity and influencing skeletal muscle regeneration. A major component of the skeletal muscle basement membrane is laminin-211 (a2, b1 and c1, merosin) [10] . Laminins play critical roles in cell surface interactions, facilitate cell-to-ECM adhesion and promote cell differentiation and proliferation [10] . In particular, laminin-211 stabilizes skeletal muscle and influences signalling from the myomatrix to muscle cells. Meanwhile, a-dystroglycan (aDG) is a major receptor for laminin-211 on skeletal muscle cells [11] . As such, we hypothesized that interactions between laminin-211 and aDG could provide stability for implanted myoblasts. Specifically, laminin a2 binds to aDG and integrin via five C-terminal G domain (LG) modules (LG1-5). Of these, LG4-5 is responsible for binding to aDG [12, 13] . As a receptor for ECM proteins such as laminin in cardiac muscle, aDG plays a primary role in muscle stability, cell signalling and development [14] . Given that laminin a2 plays an essential role in the adherence of implanted myoblasts to the host myocardium, we hypothesized that co-transplantation of myoblasts with cells expressing the laminin a2 LG4-5 domain could provide a scaffold for enhanced binding of implanted myoblasts, thereby preventing myoblast detachment. Cell transplantation is a promising therapeutic alternative to heart transplants. We consider that this cell-sheet therapeutic technique using laminin could be a new transplantation strategy for surgical heart failure treatment. We here evaluated the therapeutic effects of transplantation of multilayered sheets comprised of skeletal myoblasts and laminin expressing fibroblasts, as well as the survival rate of transplanted myoblasts, in a rat model of ischemic cardiomyopathy. Generation of a fibroblast cell line that overexpresses recombinant human laminin a2
MATERIALS AND METHODS

Animal ethics
LG4-5
Total mRNA was isolated from a human cardiomyocyte cell line (PromoCell GmbH Sickingenstr, Heidelberg, Germany), and cDNA encoding human laminin a2 LG4-5 region (amino acids: 2733-3122) was synthesized. The resulting cDNA was then ligated to the pSectag2B plasmid vector, generating LG4-5/ pSectag2B. Rat dermal fibroblasts (RDFs) were stably transfected with LG4-5/pSectag2B using zeosin for selective purposes.
Cell isolation and culturing
Skeletal myoblasts (SMBs) and myocytes were dissociated and cultured as described in the Supplementary Material.
Production and transplantation of cell sheets
RDFs or SMBs (3 Â 10 6 each) were seeded in 35-mm Upcell dishes (CellSeed, Tokyo, Japan). After culturing for 24 h at 37 C, the cells were incubated at room temperature to allow for detachment from the dish.
The rat myocardial infarction (MI) model was generated by ligation of the left anterior descending coronary artery (LAD) of 8-week-old female F344/NJcl-rnu/rnu rats (CLEA Japan, Inc., Osaka, Japan). The rats were taken intraoperative care as previously described [3] . At 2 weeks after the ligation, five cell sheets (three SMB and two RDF sheets) were implanted on the infarcted left ventricular anterior wall [15] . First, the three SMB sheets were sequentially applied to the surface of the infarcted myocardium. After confirming the adherence of the first sheet, subsequent sheets were applied using the same technique. Two RDF sheets were then similarly transplanted onto implanted SMB sheets. The MI rats were divided into four treatment groups (n = 20 in each group): those receiving SMB and normal RDF sheets (SMB + normal Fb group), SMB and laminin-secreting RDF sheets (SMB + laminin Fb group) or SMB sheets only (SMB group) and the ligation only (Control) group (Fig. 1) . Five rats in each group were subjected to echocardiography analysis at 2, 4, 6 and 8 weeks after treatment. In addition, the heart weight/body weight (HW/BW) ratio for each of these rats was assessed at 8 weeks post-treatment. For these analyses, body weights were measured and their hearts were removed as previously described [3] . The removed hearts were also used for histological and western blot analyses. The remaining 15 rats were sacrificed at 1, 2 or 4 weeks (five rats per time point) after treatment, and their hearts were subjected to implanted cell survival and enzyme-linked immunosorbent assay (ELISA) analyses.
Estimation of donor cell survival rate by quantitative reverse transcription (RT)-PCR
Five rats each in SMB, SMB + normal Fb and SMB + laminin Fb groups were sacrificed at 1, 2 and 4 weeks post-transplantation. RT-PCR was performed as previously described [16] .
Histological analysis
Hearts removed at 8 weeks post-implantation were fixed with 10% formalin and embedded in paraffin. Histological analysis was performed as previously described [3] .
Echocardiography, adhesion assay, flow cytometry, western blotting and ELISA analyses These assays were performed as described in Supplementary Date.
Statistical analysis
All data are expressed as means ± standard deviations (SD). Data were analysed by repeated-measures analysis of variance (ANOVA), while one-way ANOVA and Tukey-Kramer post-hoc tests were utilized to examine the significance of differences between data from individual groups at each time point. Probability (P) values < 0.05 were considered statistically significant.
RESULTS
Analysis of aDG binding by recombinant LG4-5
An immunoreactive signal specific to recombinant LG4-5 was detected in the lysates and culture media of RDFs transfected with LG4-5/pSectag2B, indicating that these cells successfully synthesized and secreted the LG4-5 peptide ( Fig. 2A) . Furthermore, aDG purified from C2C12 cells (Fig. 2B ) bound to the recombinant LG4-5 secreted by RDFs, as determined by in vitro pull-down and western blotting analyses (Fig. 2C ).
Adhesion properties of primary myoblasts and cardiomyocytes for the recombinant laminin
While myoblasts weakly adhered to wells coated with culture medium harvested from control fibroblasts or with Dulbecco's modified Eagle's medium (DMEM) containing 0.1% FBS, a markedly higher number of myoblasts adhered to the wells coated with culture medium obtained from LG4-5-secreting fibroblasts (Fig. 2D) . Meanwhile, cardiomyocytes from adult rats exhibited similar levels of adherence in the presence of culture medium harvested from LG4-5-secreting fibroblasts and a solution containing 5 mg/mL mouse laminin protein (positive control). In contrast, few cells adhered to the wells containing culture medium from control fibroblasts (Fig. 2E ).
Integrin expression on surface of the isolated myoblasts
The isolated SMBs expressed both integrin b3 and b1; however, integrin b1 was expressed at higher levels than b3 (Fig. 2F) .
Evaluation of the survival rates of implanted myoblasts
The survival rates of implanted myoblasts were evaluated by measuring the mRNA expression levels of nebulin, a protein specifically expressed in skeletal muscle [17] , within implanted anterior wall area. The mRNA expression levels of nebulin in SMB group gradually decreased over time after sheet transplantation. In contrast, nebulin was expressed at higher levels in SMB + laminin Fb group than in SMB group by 1 week post-sheet implantation (P < 0.01). The level of nebulin expression in this group was also higher than that in both SMB and SMB + normal Fb group at 2 weeks after sheet implantation ( Fig. 3 ; P < 0.01). Moreover, the survival rate of implanted myoblasts in SMB + laminin Fb was higher than that in SMB group up to 4 weeks after implantation (P < 0.01). However, laminin failed to prevent the complete detachment of implanted myoblasts, as evidenced by decreased nebulin expression over time in SMB + laminin Fb group.
Heart weigth/body weight ratios
The HW/BW ratios of the rats in SMB + laminin Fb group were lower than those in control and SMB groups at 8 weeks after treatment (Table 1 ; P < 0.01 vs Control group and P < 0.05 vs SMB group).
Evaluation of cardiac function by echocardiography
The cardiac performance of the control group decreased over time. Additionally, the %FS value of the SMB, SMB + normal Fb and SMB + laminin Fb groups was higher than that of the control group at all measurement points (P < 0.01). However, while these values gradually diminished in SMB and SMB + normal Fb groups at 6 and 8 weeks, the significant improvement in cardiac function observed in SMB + laminin Fb group was maintained until 8 weeks after treatment ( Fig. 4 ; at 6 weeks, P < 0.01 vs Control group and P < 0.05 vs SMB group; at 8 weeks, P < 0.01 vs Control group, SMB and SMB + normal Fb groups).
The autocrine and paracrine effects of growth factors
At both 1 and 2 weeks after sheet transplantation, there were higher levels of IGF, HGF and VEGF expression in the tissues from SMB + laminin Fb group than in those from SMB and SMB + normal Fb groups (P < 0.01 vs Control and SMB + normal Fb groups at both 1 and 2 weeks); furthermore, the expression levels of these factors in SMB + laminin Fb group was greater at 2 weeks than at 1 week (Fig. 5A , B and C). There was a similar difference in expression between these three groups at 4 weeks after sheet implantation. . After 2 weeks, the rats were then subjected to the treatment procedure. Survival rate analysis of implanted myoblasts was performed at 1, 2 and 4 weeks after sheet implantation. Cardiac function was assessed by echocardiography just prior to treatment, and at 2, 4, 6 and 8 weeks after the treatment procedure. Eight weeks after treatment, histological examinations were performed. SMB: transplantation of skeletal myoblast sheets; SMB + normal Fb: co-transplantation of SMBs and control dermal fibroblast (RDF) sheets; SMB + laminin Fb: co-transplantation of SMBs and laminin a2 LG4-5-secreting RDF sheets.
Effect of SMB sheet transplantation on apoptosis in ischemic myocardia
At 8 weeks post-implantation, there were lower levels of cleaved PARP in the infarcted areas of the tissues harvested from SMB + laminin Fb group than in those obtained from control and SMB groups. Moreover, the border areas in SMB + laminin Fb group exhibited lower levels of cleaved PARP than those in control group. (Fig. 5D and E; infarcted area, P < 0.01 vs control group and P < 0.05 vs SMB group; border area, P < 0.05 vs control group). 
Left ventricular remodelling by sheet transplantation
At 8 weeks after sheet transplantation, control group exhibited typical MI with thinning of the infarcted wall, dilatation of the LV chamber, widespread fibrosis and cardiomyocyte hypertrophy (Fig. 6) . In contrast, these effects were suppressed in the infarcted border areas of tissues in SMB + laminin Fb group, compared with those in Control (Fig. 6C , D, E and F; % anterior wall thickness, P < 0.05; dilatation of the LV chamber, P < 0.05; fibrosis, P < 0.01; cardiomyocyte hypertrophy, P < 0.01). Maintenance of the thickness of the infarcted wall was enhanced in SMB + laminin Fb group, compared with control and SMB + normal Fb groups ( Fig. 6C; P < 0.05) . Furthermore, the levels of fibrosis and cardiomyocyte hypertrophy observed in SMB + laminin Fb group were lower than those observed in SMB and SMB + normal Fb groups ( Fig. 6E and F; fibrosis, P < 0.01 vs SMB group and P < 0.05 vs SMB + normal Fb group; cardiomyocyte hypertrophy, P < 0.01 vs SMB and SMB + normal Fb groups). The capillary density was higher in the infarcted border area of SMB (P < 0.05), SMB + normal Fb (P < 0.05) and SMB + laminin Fb (P < 0.01) tissues than in those of Control group (Fig. 6G) .
DISCUSSION
In regenerative therapy for cardiomyopathy, various cell-based approaches have been investigated. In particular, autologous skeletal myoblast sheet (SMS) transplantation has been evaluated as a viable heart failure treatment in clinical trials [18] . Cell transplantation by injection is associated with several disadvantages, including the loss of transplanted cells and arrhythmogenicity. These problems can be overcome by transplantation of cell sheets using temperature-responsive Upcell dishes [2] . The cell sheets are detached from Upcell dishes without destroying cell-cell or cell-ECM adhesions. The greatest advantage of this technique is that the sheets are composed entirely of cells, which produce the ECM without requiring an artificial scaffold. These myoblast sheets exhibit a strong capacity to integrate with areas of infarction. Because cell sheets are implanted on the epicardium of host hearts, they do not migrate within the myocardium. However, the cardio-protective effects of myoblasts transplantation occur through autocrine or paracrine mechanisms [1, 18] ; therefore, implanted myoblast not need be transplanted within myocardium, as those implanted on the epicardium both secrete growth factors and induce growth factor secretion by surrounding cells.
SMB sheets implanted onto the surface of ischemic myocardia are subject to poor blood flow, resulting in reduced SMB survival. The previous study demonstrated that only 2% of implanted SMBs remained at 4 weeks after cell-sheet transplantation [7] . However, this same group also reported that co-cultivation and transplantation of sheets containing mesenchymal stem cells and SMBs resulted in enhanced survival of implanted cells by enhancing the level of angiogenesis within the sheets [7] . Several other approaches are currently under investigation, including implantation of cells genetically modified to express anti-apoptosis and angiogenic factors and implantation of cells embedded in biomaterials [3, 8] . However, these strategies rely on viral vectors or xenogenic biomatrix, and are difficult to apply clinically. By contrast, our study used human laminin and dermal fibroblasts, which can easily be harvested from patients. In this study, because cell-matrix interactions are essential for both cell attachment and survival signalling, we developed a novel cell-sheet therapeutic technique using the LG4-5 portion of laminin, which is a component of the ECM. Binding assays using recombinant LG4-5 and aDG, and adhesion assays using SMBs and adult rat cardiomyocytes revealed that the LG4-5 secreted from transfected RDFs functioned as an effective scaffold for implanted SMBs and cardiomyocytes. Furthermore, the survival rate and maintenance of implanted myoblasts in SMB + laminin Fb group was significantly higher than that in SMB and SMB + normal Fb groups at 1, 2 and 4 weeks after sheet implantation, indicating that the fibroblastproduced laminin a2 enhanced the adhesion properties of implanted myoblasts to host myocardia. Meanwhile, in vitro adhesion assay analyses demonstrated that myoblasts adhered to the culture media harvested from both control fibroblasts and fibroblasts producing recombinant laminin a2, suggesting that there is a factor or matrix produced by normal fibroblasts that affects the survival of implanted myoblasts. Subsequent flow cytometry analyses detected surface expression of integrin b3, which is known to bind fibronectin [19] , by myoblasts, indicating that myoblasts may interacted via integrin b3 with fibronectin derived from fibroblasts.
The laminin secreted from fibroblasts enhanced the survival of myoblasts on the host myocardium for approximately 4 weeks, thereby improving the therapeutic effects of the transplanted SMB sheets. According to a previous study [7, 8] , a 4-week survival rate of 1-2% for traditional SMB sheets indicates that cotransplantation with laminin resulted in it of approximately 10%. However, laminin failed to fully prevent the detachment of implanted myoblasts, as indicated by a trend towards decreasing mRNA expression of nebulin in SMB + laminin Fb group over time, which could be due nutritional deficiencies in implanted cells.
The autocrine and paracrine effects of growth factors which improve heart function comprise a major component of the regenerative mechanism resulting from myoblast sheet implantation. The upregulation of these factors promotes angiogenesis, stimulates hematopoietic stem-cell recruitment, and is associated with anti-remodelling effects, resulting in improved cardiac function [20] . Quantification of growth factor production by ELISA analysis revealed increased expression of these factors in the myocardia of SMB + laminin Fb group compared to that observed in SMB and SMB + normal Fb tissues. Due to the enhanced survival rate of implanted myoblasts via interaction with laminin, the autocrine and paracrine effects of cytokines that improve heart function was also maintained, leading to long-term improvement in cardiac function. While nebulin was expressed at relatively low levels in SMB + laminin Fb group at 4 weeks post-transplantation, the survival rate of implanted myoblasts in this group was significantly higher than that in SMB group up to 4 weeks after implantation; however there was no significant difference in nebulin expression between SMB + laminin Fb and SMB + normal Fb groups after 4 weeks. The tissues in SMB + laminin Fb group exhibited 6-12-fold higher expression of nebulin than those of SMB and SMB + normal Fb groups at 2 weeks after sheet implantation. In traditional myoblast sheet implantation, such as in SMB group, the majority of the transplanted myoblasts detach from the host myocardium between the first and second week after implantation, and this loss of cells is accompanied by a decrease in the paracrine effects of implanted myoblasts. Consistent with these findings, in this study, the tissues in SMB + laminin Fb group exhibited peak myoblast survival rates and peak IGF, HGF and VEGF expression levels at 2 weeks post-implantation; however, there were no significant differences in the levels of these factors after 4 weeks among three groups. We predict that this temporarily high level of growth factor secretion, particularly in SMB + laminin Fb group, was essential for the observed therapeutic effects of the myoblasts sheets, including the inhibition of LV remodelling and cardiac dysfunction. We predicted that the use of laminin would prevent myoblast detachment for approximately 4 weeks after implantation, which was 2 weeks longer than that observed for traditional cell-sheet implantation methods. Indeed, although the survival rate of implanted myoblasts in SMB + laminin Fb group was relatively low at 4 weeks after treatment, the laminin secreted from implanted fibroblasts enhanced the therapeutic effect of SMB sheets by promoting transient paracrine effects.
At 8 weeks after sheet transplantation, cleaved PARP level was present at lower levels in both the infarcted and border areas of the tissues harvested from rats in SMB + laminin Fb group. Histological assessment detected attenuated LV chamber dilation, myocardial fibrosis and cardiomyocyte hypertrophy in SMB + laminin Fb group compared to the levels observed in tissues of SMB and SMB + normal Fb groups. The capillary densities of the infarcted border areas of SMB + laminin Fb group were also higher than those in SMB group. These effects likely resulted from the elevated continuous secretion of growth factors by implanted myoblasts, the survival of which was enhanced by the presence of laminin. While there were significant improvements in %FS values in SMB and SMB + normal Fb groups compared with control group, there was a marked decrease in these functions between 6 and 8 weeks post-implantation. In contrast, the improved cardiac function observed in SMB + laminin Fb group was maintained until 8 weeks after transplantation. Our findings therefore indicate that the decreased function observed in SMB and SMB + normal Fb rats resulted from detachment of implanted myoblasts from the host myocardia.
The laminin secreted by implanted fibroblasts inhibited detachment of implanted myoblasts from rat myocardia, and the co-transplantation of myoblast sheets with laminin-expressing fibroblasts resulted in enhanced therapeutic effects. This recombinant LG4-5 has been combined, not only with myoblasts, but also with isolated adult rat cardiomyocytes. There has been considerable research on SMS transplantation, and many studies have indicated that this transplantation approach is useful in cases of heart failure. In contrast, cardiomyocyte implantation is still in the investigational stage. Therefore, in this study, we used myoblast sheets to comparatively evaluate the therapeutic effects and survival rate of the implanted cells. However, cardiomyocytes from adult rats also exhibited high adhesion to the recombinant laminin. We anticipate that the application of this method will be assessed for various cell-based transplantation methods, particularly those using stem cell-derived cardiomyocytes and various musclelike cells for failing hearts.
LIMITATIONS
In this study nebulin was used as the sole marker for evaluating the survival rates of implanted myoblasts. By measuring the expression levels of other myofiber proteins, the role of laminin in increased survival rates could be evaluated more accurately. And, the therapeutic effects of transfected fibroblast sheets were not evaluated in this study. For a more detailed and accurate analysis of the effects of laminin LG4-5 on the survival of myoblast sheets, evaluation of a rat group that was transplanted with transfected fibroblast sheets alone is needed. Analysis of the therapeutic effects of such sheets would confirm the results presented in this study regarding the effects of laminin LG4-5 on myoblast sheet survival.
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